Point-Of-Care Or Rapid Diagnostics Industry Research Report 2024

Point-Of-Care Or Rapid Diagnostics Industry Research Report 2024


Summary

According to APO Research, the global Point-Of-Care Or Rapid Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Point-Of-Care Or Rapid Diagnostics include Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.

The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Point-Of-Care Or Rapid Diagnostics segment by Type

Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Point-Of-Care Or Rapid Diagnostics segment by Application

Hospital
Clinic
Independent Laboratories
Others
Point-Of-Care Or Rapid Diagnostics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-Of-Care Or Rapid Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size (2019-2030) & (US$ Million)
2.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales (2019-2030)
2.2.3 Global Point-Of-Care Or Rapid Diagnostics Market Average Price (2019-2030)
2.3 Point-Of-Care Or Rapid Diagnostics by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Intensive Care
2.3.3 Covid-19 Testing
2.3.4 Infectious Diseases Testing
2.3.5 Cardiac Markers Testing
2.3.6 Coagulation Testing
2.3.7 Others
2.4 Point-Of-Care Or Rapid Diagnostics by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Independent Laboratories
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Point-Of-Care Or Rapid Diagnostics Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Point-Of-Care Or Rapid Diagnostics Revenue of Manufacturers (2019-2024)
3.4 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Global Point-Of-Care Or Rapid Diagnostics Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
3.8 Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
3.9 Global Point-Of-Care Or Rapid Diagnostics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.1.5 Roche Recent Developments
4.2 Abbott
4.2.1 Abbott Company Information
4.2.2 Abbott Business Overview
4.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.2.5 Abbott Recent Developments
4.3 Danaher
4.3.1 Danaher Company Information
4.3.2 Danaher Business Overview
4.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.3.5 Danaher Recent Developments
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Company Information
4.4.2 Siemens Healthcare Business Overview
4.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.4.5 Siemens Healthcare Recent Developments
4.5 Bio-Rad Laboratories
4.5.1 Bio-Rad Laboratories Company Information
4.5.2 Bio-Rad Laboratories Business Overview
4.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.5.5 Bio-Rad Laboratories Recent Developments
4.6 BioMerieux
4.6.1 BioMerieux Company Information
4.6.2 BioMerieux Business Overview
4.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.6.5 BioMerieux Recent Developments
4.7 Nova Biomedical
4.7.1 Nova Biomedical Company Information
4.7.2 Nova Biomedical Business Overview
4.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.7.5 Nova Biomedical Recent Developments
4.8 Thermo Fisher Scientific
4.8.1 Thermo Fisher Scientific Company Information
4.8.2 Thermo Fisher Scientific Business Overview
4.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.8.5 Thermo Fisher Scientific Recent Developments
4.9 Quidel
4.9.1 Quidel Company Information
4.9.2 Quidel Business Overview
4.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.9.5 Quidel Recent Developments
4.10 A. Menarini Diagnostics
4.10.1 A. Menarini Diagnostics Company Information
4.10.2 A. Menarini Diagnostics Business Overview
4.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.10.5 A. Menarini Diagnostics Recent Developments
4.11 Becton Dickinson
4.11.1 Becton Dickinson Company Information
4.11.2 Becton Dickinson Business Overview
4.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.11.5 Becton Dickinson Recent Developments
4.12 Biosurfit
4.12.1 Biosurfit Company Information
4.12.2 Biosurfit Business Overview
4.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.12.5 Biosurfit Recent Developments
4.13 Astrego Diagnostics
4.13.1 Astrego Diagnostics Company Information
4.13.2 Astrego Diagnostics Business Overview
4.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.13.5 Astrego Diagnostics Recent Developments
4.14 Werfen
4.14.1 Werfen Company Information
4.14.2 Werfen Business Overview
4.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.14.5 Werfen Recent Developments
4.15 Abionic
4.15.1 Abionic Company Information
4.15.2 Abionic Business Overview
4.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.15.5 Abionic Recent Developments
4.16 Palex Medical/Bülhmann
4.16.1 Palex Medical/Bülhmann Company Information
4.16.2 Palex Medical/Bülhmann Business Overview
4.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.16.5 Palex Medical/Bülhmann Recent Developments
4.17 Horiba Medical
4.17.1 Horiba Medical Company Information
4.17.2 Horiba Medical Business Overview
4.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.17.5 Horiba Medical Recent Developments
4.18 RAL
4.18.1 RAL Company Information
4.18.2 RAL Business Overview
4.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.18.5 RAL Recent Developments
4.19 Vircell
4.19.1 Vircell Company Information
4.19.2 Vircell Business Overview
4.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.19.5 Vircell Recent Developments
4.20 Monlab
4.20.1 Monlab Company Information
4.20.2 Monlab Business Overview
4.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.20.5 Monlab Recent Developments
4.21 Binding Site
4.21.1 Binding Site Company Information
4.21.2 Binding Site Business Overview
4.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
4.21.5 Binding Site Recent Developments
5 Global Point-Of-Care Or Rapid Diagnostics Market Scenario by Region
5.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2019-2030
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2019-2024
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2025-2030
5.3 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2019-2030
5.3.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2019-2024
5.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2025-2030
5.4 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.4.1 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
5.4.3 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
5.4.4 United States
5.4.5 Canada
5.5 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.5.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
5.5.3 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.6.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
5.6.3 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.7.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
5.7.3 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
5.8.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
5.8.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
6.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2019-2030)
6.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2019-2030)
6.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
7 Segment by Application
7.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
7.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030) & (K Doses)
7.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2019-2030)
7.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
7.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2019-2030)
7.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Point-Of-Care Or Rapid Diagnostics Value Chain Analysis
8.1.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
8.2 Point-Of-Care Or Rapid Diagnostics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Point-Of-Care Or Rapid Diagnostics Distributors
8.2.3 Point-Of-Care Or Rapid Diagnostics Customers
9 Global Point-Of-Care Or Rapid Diagnostics Analyzing Market Dynamics
9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
9.2 Point-Of-Care Or Rapid Diagnostics Industry Drivers
9.3 Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
9.4 Point-Of-Care Or Rapid Diagnostics Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings